LIVN LivaNova PLC
$80.38▼ -0.30%
Healthcare
Other
After hours
$80.38▲ +0.00%
Oct 27, 4:01 PM ET
Volume 383.6K
Avg Volume (10D) 552.3K
Key Metrics & Fundamentals
Market Cap
$4.42B
P/E Ratio
23.8
Div Yield
0.00%
52W Range
48.82 - 85.76
% vs 50 MA
2.45%
% vs 200 MA
10.69%
RSI-14
57.9
MACD Histogram
+0.5300
Beta (1Y vs SPY)
0.95
Free Cash Flow
$35.04M
Gross Rev
$390.59M
Gross Profit
$273.67M
EBITDA
$71.62M
COGS
$116.92M
Operating Exp
$224.19M
Operating Income
$49.48M
EBIT
$49.48M
Pretax Income
$18.48M
Net Income
$108.57M
EPS (Diluted)
1.93
Price & Volume History
Loading chart…
Recent News

Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant Epilepsy
Business Wire · Oct 23, 2026 9:00 AM ET

LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November
Business Wire · Oct 21, 2026 9:00 AM ET

Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors
Exec Edge · Oct 20, 2026 6:03 PM ET

LivaNova (LIVN) Stock Looks Undervalued As Its 60% Three Year Run Continues
Simply Wall St. · Oct 9, 2026 5:17 PM ET

LivaNova (LIVN) Narrative Keeps Fair Value In Focus As Shares Cool
Simply Wall St. · Oct 9, 2026 2:11 PM ET

Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · Oct 7, 2026 10:00 AM ET

Operating Leverage and Product Innovation Drive LivaNova’s(LIVN) Sustained Profit Outlook
Insider Monkey · Sep 24, 2026 9:50 AM ET

LivaNova to Announce Third-Quarter 2026 Results
Business Wire · Sep 23, 2026 9:00 AM ET
Livanova Insider Sold Shares Worth $273,032, According to a Recent SEC Filing
MT Newswires · Sep 14, 2026 4:28 PM ET

LivaNova Director Sells 1,650 Shares for $131,500
Motley Fool · Sep 10, 2026 9:15 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LIVN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.